Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Aster DM Healthcare Limited Call Transcript 2021

Feb 5, 2021

62551_rns_2021-02-05_d976393d-e7fc-4d63-83c7-f26084ee940a.pdf

Call Transcript

Open in viewer

Opens in your device viewer

==> picture [93 x 91] intentionally omitted <==

February 05, 2021

The Secretary The Manager, Listing Department, Listing Department, BSE Limited, The National Stock Exchange of India Ltd 1[st] Floor, Phiroze Jeejeebhoy Towers Exchange Plaza, C-1, Block G Dalal Street, Mumbai 400001 Bandra Kurla Complex Scrip Code: 540975 Bandra (East), Mumbai 400051 Scrip Symbol: ASTERDM

Dear Sir/ Madam,

Sub: Intimation of conference-call with Analyst/Institutional Investor under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please be informed that an Analysts/ Institutional Investor call is scheduled to be held on Wednesday, February 10, 2021 at 11:30 am (IST) .

Enclosed please find the details of the proposed Analysts/ Institutional Investor call.

We request you to kindly take the above information on record.

Thank You,

For Aster DM Healthcare Limited

==> picture [72 x 48] intentionally omitted <==

Puja Aggarwal Company Secretary and Compliance Officer

Aster DM Healthcare Limited

CIN- L85110KL2008PLC021703 IX/475L, Aster Medcity,Kuttisahib Road Near Kothad Bridge, South Chittoor PO Cheranalloor, Kochi- 682027, Kerala, India Tel: +91 484 6699999, Fax: +91 484 6699862 Email:[email protected]

==> picture [143 x 39] intentionally omitted <==

==> picture [78 x 77] intentionally omitted <==

Investor Conference Call

Elara Securities (India) Private Limited is pleased to invite you to a Conference Call with

Aster DM Healthcare Limited

represented by

Dr. Azad Moopen , Chairman and Managing Director Ms. Alisha Moopen, Deputy Managing Director Mr. Sreenath Reddy, Group Chief Financial Officer Dr. Harish Pillai , CEO - India

Subject: Conference call to discuss Q3FY21 results

Date: Wednesday, 10 February 2021

Time: 11.30 AM IST

06.00 AM (UK) - 2.00 PM (Singapore, Hong Kong) 01.00 AM (East Coast, US) - 10.00 PM (West Coast, US)

Diamond Pass Login: click here for Registration

Dial in Numbers:

Universal & Mumbai +91 22 6280 1146 +91 22 7115 8047

Local Access Number +91 70456 71221

Toll Free Numbers US: 1 866 746 2133 UK: 0 808 101 1573 Singapore: 800 101 2045 Hong Kong: 800 964 448 Australia: 1800053698

RSVP Param Desai l [email protected] l +91 22 6164 8528/+91 90044 94914

India Europe USA Asia / Pacific Elara Securities (India) Pvt. Ltd. Elara Capital Plc. Elara Securities Inc. Elara Capital (Asia) Pte.Ltd. Indiabulls Finance Centre, 6th Floor, The Grove, 950 Third Avenue, 1 Raffles Place, #42-03 Tower 3, 21st Floor, 248A Marylebone Road, Suite 1903, New York, One Raffles Place Senapati Bapat Marg, London, NW1 6JZ NY 10022, USA Singapore 048616 Elphinstone Road (West) United Kingdom Tel: +1 212 430 5870 Tel : +65 6692 0174 Mumbai – 400 013, India Tel : +44 20 7486 9733 Fax: +1 212 208 2501 Tel : +91 22 6164 8500

Dubai Elara Capital (Middle East) 202 Currency House, DIFC, Dubai, UAE Tel: 00 971 43860981 Fax: 00 971 43860989